Welcome to our dedicated page for FINNOVATE ACQ A news (Ticker: FNVTF), a resource for investors and traders seeking the latest updates and insights on FINNOVATE ACQ A stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FINNOVATE ACQ A's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FINNOVATE ACQ A's position in the market.
Finnovate Acquisition Corp. (OTC: FNVUF) has announced the postponement of its extraordinary general meeting of shareholders to February 27, 2025, at 10:00 AM ET. The meeting aims to approve the proposed initial business combination with Scage International .
The postponement is specifically to allow Scage International additional time to obtain required listing approvals from the China Securities Regulatory Commission (CSRC), which is a condition for completing the business combination. The meeting will be held via webcast at https://www.cstproxy.com/finnovateacquisition/2025.
The deadline for Class A ordinary shareholders to submit shares for redemption has been extended to February 25, 2025, at 5:00 PM ET. Only shareholders of record as of January 6, 2025, are eligible to vote at the meeting.
FAQ
What is the current stock price of FINNOVATE ACQ A (FNVTF)?
What is the market cap of FINNOVATE ACQ A (FNVTF)?
